Phenox
Bochum, Nordrhein-Westfalen, Germany
About Phenox
Phenox develops and produces neuroradiological and radiological medical products. It offers instruments for acute ischemic strokes/aneurysms that include PCR, a miniature instrument, that aids the restoration of blood flow in the area of the brain arteries affected by an acute ischemic stroke; CRC, a mechanical thrombectomy system for the treatment of acute ischemic strokes; BONNET for the treatment of acute ischemic strokes; BONNET short, an intracranial flow restoration device; p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections, pCONUS Bifurcation Aneurysm Implant, to treat complex, wide-neck intracranial bifurcation aneurysms; pITA RX Neurovascular PTA Balloon Catheter; and pRESET, a thrombectomy retriever for the treatment of acute ischemic strokes. Phenox also provides implants for hemorrhagic strokes/aneurysms, including flow diverters and pORTAL Hydrophilic Steerable Guidewire. It distributes its products in Germany and internationally. Phenox began operation in 2005. It has its headquarters in Bochum in Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series Unknown (Aug 2010)
- Website: phenox.net
- Phone: +49 (0) 234-36 919-0
Industries & Categories
Biotechnology, Medical, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/phenox-2546558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.